|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Obesity | |||||
| 2 | More general conditions related to this trial | ||||
| Body Weight | |||||
| Nutrition Disorders | |||||
| Overnutrition | |||||
| Overweight | |||||
| Signs and Symptoms | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| 5-Hydroxytryptophan | |||||
| 4 | More general drug interventions related to this trial | ||||
| Antidepressive Agents | |||||
| Antidepressive Agents, Second-Generation | |||||
| Central Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Psychotropic Drugs | |||||
| Therapeutic Uses | |||||
| 5 | Sponsors listed in this trial | ||||
| TNO Quality of Life | |||||
| Laboratoire Oenobiol | |||||